PTC Therapeutics, Inc. Unrecognized Tax Benefits, Period Increase (Decrease)
PTC Therapeutics, Inc. (PTCT) reported Unrecognized Tax Benefits, Period Increase (Decrease) of -$92.92 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2026-02-19
- PTC Therapeutics, Inc. unrecognized tax benefits, period increase (decrease) for fiscal 2025 was -$92.92M, a 187.15% decline from fiscal 2024.
- PTC Therapeutics, Inc. unrecognized tax benefits, period increase (decrease) for fiscal 2024 was $106.63M.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 12 month |
|---|---|
| 2025-12-31 | -$92.92M 10-K · filed 2026-02-19 |
| 2024-12-31 | $106.63M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |